Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hero

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Frontiers in Pediatrics|October 27, 2022
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)Stefania Sorrentino, Shifra Ash, Riccardo Haupt, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
Cancers|January 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort StudyTim Flaadt, Jonas Rehm, Thorsten Simon, et al.
Radiology. Artificial Intelligence|June 12, 2024
Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma TumorsDiana Veiga-Canuto, Matías Fernández-Patón, Leonor Cerdà Alberich, et al.
JCO Precision Oncology|December 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation StudyNina U Gelineau, Lieke M J van Zogchel, Boris De Carolis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Radiology|May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group ProjectHervé J Brisse, M Beth McCarville, Claudio Granata, et al.
Bone Marrow Transplantation|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastomaSveva Castelli, Tim Flaadt, Franziska Schulze, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Frontiers in Pediatrics|October 27, 2022
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)Stefania Sorrentino, Shifra Ash, Riccardo Haupt, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
Cancers|January 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort StudyTim Flaadt, Jonas Rehm, Thorsten Simon, et al.
Radiology. Artificial Intelligence|June 12, 2024
Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma TumorsDiana Veiga-Canuto, Matías Fernández-Patón, Leonor Cerdà Alberich, et al.
JCO Precision Oncology|December 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation StudyNina U Gelineau, Lieke M J van Zogchel, Boris De Carolis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Radiology|May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group ProjectHervé J Brisse, M Beth McCarville, Claudio Granata, et al.
Bone Marrow Transplantation|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastomaSveva Castelli, Tim Flaadt, Franziska Schulze, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
Pageof 15